Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Expands By 142.7%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 63,600 shares, an increase of 142.7% from the March 31st total of 26,200 shares. Currently, 11.6% of the company’s shares are short sold. Based on an average daily trading volume, of 1,220,000 shares, the days-to-cover ratio is currently 0.1 days.

China SXT Pharmaceuticals Price Performance

Shares of NASDAQ:SXTC traded up $0.02 during trading on Friday, hitting $1.05. 203,439 shares of the company’s stock were exchanged, compared to its average volume of 2,344,629. China SXT Pharmaceuticals has a 1-year low of $0.94 and a 1-year high of $9.38. The firm has a 50-day moving average price of $1.68 and a two-hundred day moving average price of $2.01. The company has a quick ratio of 1.41, a current ratio of 1.47 and a debt-to-equity ratio of 0.02.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.